IL21 and glioblastoma: In the work of Zhenjiang and colleagues [115], the peripheral blood of patients with glioblastoma was analyzed (glioblastoma = 145; non-glioblastoma = 60) to measure the circulating T cells in the absence or presence of serum cytokines such as IL-2/IL-15/IL-21.